BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20220915T194500
DTEND;TZID=Africa/Nairobi:20220915T204500
DTSTAMP:20230602T130342Z
CREATED:20230524T222622Z
LAST-MODIFIED:20230602T130342Z
UID:7886-1663271100-1663274700@kesho-kenya.org
SUMMARY:Prostate Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nProf Mack Roach \nProfessor Mack Roach III\, MD\, is a Professor of Radiation Oncology\, Medical Oncology and Urology\, at the University of California\, San Francisco. Roach earned his MD from Stanford University School of Medicine. His major research interest involves the application of 3-D conformal and intensity modulated radiotherapy (IMRT) treatment planning technology as a major component of combined modality management of prostate cancer and other solid tumors. Over the last 10 years\, his research efforts have been directed at defining optimal imaging modalities\, as well as criteria for defining target volumes and improved treatment techniques. \nProf Roach chaired one of the most important large prospective randomized trials comparing different strategies for locally advanced prostate cancer. He has gained international recognition as an authority on treatment planning for prostate cancer and served as senior author for the guidelines for treatment planning recently published by the American College of Radiology. \nProf Roach is a member of several professional societies including the American Society of Clinical Oncology\, American Society for Therapeutic Radiology and Oncology\, Radiation Therapy Oncology Group\, the NCI IMRT Working Group and American Joint Commission for Cancer (AJCC) Staging (GU)\, the American Cancer Society (ACS) Task for Cancer Screening Guidelines (Prostate cancer) and the NCI Concept Evaluation Panel (Prostate Cancer Phase III Trials). \nProf Silke Gillessen\nProfessor Silke Gillessen is a Medical Oncologist with focus on genitourinary cancer. \nShe completed her training in Basel\, St. Gallen\, and the Dana Farber Cancer Institute\, Boston. After returning to Switzerland\, she built up the medical oncology unit for genitourinary cancer and headed the clinical research unit for oncology/haematology in Cantonal Hospital\, St Gallen. \nShe served for two terms as president of the SAKK GU group\, she chaired the EORTC Genitourinary Cancers Group\, and has founded the Advanced Prostate Cancer Consensus Conference (APCCC). \nSince 2018\, Prof Gillessen has been Genitourinary Cancer Systemic Therapy Research Chair at the University of Manchester and Honorary Consultant at The Christie Hospital\, while continuing to work as Consultant in the Department of Oncology/Haematology at the Kantonsspital St. Gallen\, Switzerland. \nIn January 2020 Prof Gillessen was appointed Head of the Department of Medical Oncology\, full professor at the Università della Svizzera Italiana (USI) in Lugano and Director of the Oncology Institute of Southern Switzerland (IOSI) in Bellinzona\, Switzerland. \nDr Samuel Nguku\nDr Samuel Nguku is a Consultant in Radiology and Nuclear Medicine at Aga Khan University Hospital Nairobi. \nHe has a master’s degree in Radiology from Aga Khan University and fellowship in Nuclear medicine from Imperial College London. \nDr Nguku was integral in setting up of the first PET CT service in Kenya at the Aga Khan University Hospital Nairobi. \nHe has great passion in improving cancer imaging in the country and integrating molecular imaging in management of cancer patients. \nModerator: Dr Angela Waweru \nDr Angela Waweru is a Consultant Clinical Oncologist and Section Head of Radiation Oncology at Aga Khan University Hospital\, Nairobi. \nShe graduated from the University of Sheffield and undertook her Core Medical and Clinical Oncology training in Sheffield Teaching Hospitals NHS Trust where she received her certificate of completion of training in 2015 and thereafter took on a Consultant Clinical Oncologist position within the same trust. \nShe is passionate about increased uptake of advanced radiation technological advances that achieve better outcomes and less toxicity. She has been instrumental at starting advanced radiation services at a leading health care facility in Nairobi. She has also promoted public private partnerships within radiation oncology and in 2022 started a pathway for treating patients requiring more conformal techniques of treatment not readily available at their institutions. \nDr Waweru is keen on promoting radiotherapy governance\, she has started radiotherapy safety committees\, peer review meetings and service development projects that benchmark local activities against standard guidelines. \nShe is a Fellow of the Royal College of Radiologist (Clinical Oncology faculty)\, Member of the Royal College of Physicians and Kenya Society of Haematology and Oncology.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column]    \n    	\n                	Recording                \n        \n    \n    [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"]    	\n        Access our Membership Page        \n        [/vc_column_inner][vc_column_inner width="1/3"]    	\n        Fill in the Membership Form        \n        [/vc_column_inner][vc_column_inner width="1/3"]    	\n        Access Membership Portal        \n        [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/prostate-cancer-4/
CATEGORIES:CME 2022,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/prostate-cancer-15-sept.jpg
END:VEVENT
END:VCALENDAR